Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cancer Genetics Inc (CGIX)

0.925 -0.005 (-0.54%)

05-21 15:55

Open:

0.93

Pre. Close:

0.93

High:

0.93

Low:

0.89

Volume:

14,839

Market Cap:

26M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.932 - 0.937

0.937 - 0.94

Low:

0.878 - 0.884

0.884 - 0.889

Close:

0.921 - 0.931

0.931 - 0.938

Technical analysis  (as of: 2018-05-21 4:27:39 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 1.42     One year: 1.71

Support:

Support1: 0.82    Support2: 0.68

Resistance:

Resistance1: 1.22    Resistance2: 1.46

Pivot:

0.91

Moving Averages:

MA(5): 0.92     MA(20): 0.92

MA(100): 1.57     MA(250): 2.54

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.11

%K %D:

%K(14,3): 63.24     %D(3): 57.90

RSI:

RSI(14): 40.57

52-Week:

High: 4.35  Low: 0.82  Change(%): -77.2

Average Vol(K):

3-Month: 77493  10-Days 13028

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CGIX has closed below upper band by 32.4%. Bollinger Bands are 76.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CGIX's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T13:30:00-04:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX

2018-05-15T14:36:44-04:00
Cancer Genetics, Inc. 2018 Q1 - Results - Earnings Call Slides

2018-05-15T12:19:10-04:00
Cancer Genetics' (CGIX) CEO Jay Roberts on Q1 2018 Results - Earnings Call Transcript

2018-05-15T07:02:22-04:00
Cancer Genetics misses by $0.03, misses on revenue

2018-05-10T20:31:00-04:00
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Cancer Genetics, Inc. Investors (CGIX)

2018-05-05T08:00:00-04:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - CGIX

2018-05-01T17:05:00-04:00
EQUITY NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Cancer Genetics, Inc. - CGIX

2018-04-27T19:15:00-04:00
RM LAW Announces Class Action Lawsuit Against Cancer Genetics, Inc.

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Healthcare Facilities Services

Shares Out. (M)

27.75

Shares Float (M)

24.48

% Held by Insiders

11.80

% Held by Institutions

17.90

Shares Short (K)

918

Shares Short Prior Month (K)

1270

Stock Financials

EPS

-0.780

EPS Est. Current Year

-0.860

EPS Est. Next Year

-0.260

EPS Est. Next Quarter

-0.100

Forward EPS

-0.290

Book Value (p.s.)

0.920

PEG Ratio

-0.05

Profit Margin

-51.00

Operating Margin

-63.95

Return on Assets (ttm)

-44.1

Return on Equity (ttm)

-79.7

Qtrly Rev. Growth

4.1

Gross Profit (p.s.)

0.316

Sales Per Share

EBITDA (p.s.)

-0.414

Qtrly Earnings Growth

Operating Cash Flow (M)

-13.56

Levered Free Cash Flow (M)

-8.46

atoplab.com

Valuation

P/E

-1.19

P/E Growth Ratio

-0.01

P/BV

1.01

P/S

18204788.00

P/CF

-1.89

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.